StockData
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc. (PTCT) stock

PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)

Close on Nov 17, 2026Market cap $5.04BP/E –Yield –

PTC Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

PTC Therapeutics's gross margin for the twelve months ending Dec 31, 2019 was 96.0%. For fiscal 2019 it was 96.0%, against 95.2% the year before. The highest annual figure on record is 100.0% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 201996.0%+0.8
FY2018Dec 31, 201895.2%−2.4
FY2017Dec 31, 201797.6%−2.4
FY2016Dec 31, 2016100.0%+0.0
FY2015Dec 31, 2015100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2019Dec 31, 201996.3%+0.7
Q3 FY2019Sep 30, 201995.8%+1.9
Q2 FY2019Jun 30, 201996.2%−0.0
Q1 FY2019Mar 31, 201995.6%+1.0
Q4 FY2018Dec 31, 201895.6%−0.2
Q3 FY2018Sep 30, 201893.9%−2.4
Q2 FY2018Jun 30, 201896.3%−2.2
Q1 FY2018Mar 31, 201894.6%−5.3
Q4 FY2017Dec 31, 201795.8%−4.2
Q3 FY2017Sep 30, 201796.2%–
Q2 FY2017Jun 30, 201798.4%–
Q1 FY2017Mar 31, 201799.9%–
Q4 FY2016Dec 31, 2016100.0%–

More PTC Therapeutics figures

See a number that looks wrong?